Bank of America
CRXT

Bank of America’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bank of America’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$1K – 8935
2021
Q3 		$1K Sell
100
-158,025
-100% -$1.42M ﹤0.01% 8052
2021
Q2 		$1.59M Hold
158,125
– – ﹤0.01% 4509
2021
Q1 		$1.59M Buy
+158,125
New +$1.59M ﹤0.01% 4451

Other funds holding CRXT

BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIA
Powell Investment Advisors Miami, Florida $317M AUM 26.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America's CRXT Position: Q4 2021 in Review

Bank of America sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Bank of America first reported a position in CRXT in Q1 2021 and held it in 3 quarters. The position peaked at $1.59M in Q2 2021. 12 funds tracked by Wall St. Rank hold CRXT as of Q4 2021.

  • Bank of America reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Bank of America sold 100 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • Bank of America first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Bank of America's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $1.59M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.